Cargando…
Oral Low-Dose Naltrexone in the Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris: An Uncontrolled Open-Label Prospective Study
Background Frontal fibrosing alopecia (FFA) and lichen planopilaris (LPP) is scarring alopecias with limited evidence supporting their treatment options. We investigated the use of low-dose naltrexone (3 mg oral daily) as adjunctive therapy in the treatment of FFA and LPP. Methods A single-center, u...
Autores principales: | Hamel, Remi K, Chen, Ling, O’Connell, Cailin, Mann, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950001/ https://www.ncbi.nlm.nih.gov/pubmed/36843712 http://dx.doi.org/10.7759/cureus.34169 |
Ejemplares similares
-
Focal and diffuse fibrosing alopecias: Classical lichen planopilaris, frontal fibrosing alopecia, fibrosing alopecia with a pattern distribution, cicatricial pattern hair loss, and lichen planopilaris diffuse pattern
por: Du, Xufeng, et al.
Publicado: (2020) -
Valchlor(®) in the Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Single Arm, Open-label, Exploratory Study
por: Pincelli, Thais P., et al.
Publicado: (2020) -
Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features()
por: Fechine, Carolina Oliveira Costa, et al.
Publicado: (2022) -
Vitamin D deficiency among patients with lichen planopilaris or frontal fibrosing alopecia
por: Ali, Shaheir, et al.
Publicado: (2022) -
Alopecia Areata Mimicking Frontal Fibrosing Alopecia
por: Trindade de Carvalho, Lara, et al.
Publicado: (2021)